Jefferies Revises Models and Price Targets on Life Science Tools, Diagnostics and Dental Companies
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Jefferies revised models & price targets for 5 different Tools/Diagnostics/Dental companies, including: CPHD (PT to $34 from $28), GHDX (PT to $27 from $25), LMNX, OPK, and XRAY.
Analyst Brandon Couillard commented, "We are publishing revised models & price targets for 5 various Life Science Tools, Diagnostics & Dental companies following 2Q16 earnings season, including CPHD, GHDX, OPK, LMNX & XRAY. We are also adjusting our PDCO model ahead of its 1Q17 results next week. Our top picks by sub-sector are: Tools—BIO, BRKR, DHR, VWR; Diagnostics—EXAS, QTNT; Dental—ALGN, XRAY; Tech/Special Sit—KEYS."
Shares of Cepheid closed at $36.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Cuts Price Target on Entergy (ETR) to $74 Following new Guidance
- RBC Capital Cuts Price Target on Pentair (PNR) to $66 Following 3Q Report
- Imperial Capital Raises Price Target on Spirit Airlines (SAVE); Cuts 4Q Estimates
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change
Related EntitiesJefferies & Co, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!